AI assistant
BIOGEN INC. — Director's Dealing 2013
Mar 12, 2013
30291_dirs_2013-03-12_85be21f4-e8c6-4487-9b41-6022b72e469a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOGEN IDEC INC. (BIIB)
CIK: 0000875045
Period of Report: 2013-03-11
Reporting Person: PAPADOPOULOS STELIOS (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-03-11 | Common Stock | M | 35000 | $59.17 | Acquired | 49950 | Direct |
| 2013-03-11 | Common Stock | S | 31034 | $172.081 | Disposed | 18916 | Direct |
| 2013-03-11 | Common Stock | S | 3966 | $172.723 | Disposed | 14950 | Direct |
| 2013-03-11 | Common Stock | M | 5700 | $59.17 | Acquired | 20650 | Direct |
| 2013-03-11 | Common Stock | S | 5700 | $172.446 | Disposed | 14950 | Direct |
| 2013-03-11 | Common Stock | M | 5975 | $53.43 | Acquired | 20925 | Direct |
| 2013-03-11 | Common Stock | S | 5975 | $172.666 | Disposed | 14950 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-03-11 | Stock Option (Right to Buy) | $59.17 | M | 35000 | Disposed | 2018-06-18 | Common Stock (35000) | Direct |
| 2013-03-11 | Stock Option (Right to Buy) | $59.17 | M | 5700 | Disposed | 2018-06-18 | Common Stock (5700) | Direct |
| 2013-03-11 | Stock Option (Right to Buy) | $53.43 | M | 5975 | Disposed | 2019-06-02 | Common Stock (5975) | Direct |
Footnotes
F1: Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
F2: Full information regarding the number of shares sold at each separate price will be provided upon request by the SEC staff, the issuer, or a security holder of the issuer.
F3: This represents the weighted average price for shares sold at a range between $171.68 (low) and $172.68 (high).
F4: This represents the weighted average price for shares sold at a range between $172.68 (low) and $172.79 (high).
F5: This represents the weighted average price for shares sold at a range between $171.80 (low) and $172.75 (high).
F6: This represents the weighted average price for shares sold at a range between $172.59 (low) and $172.75 (high).
F7: Granted under one of the Issuer's stock option plans, in an exempt transaction under SEC Rule 16(b)-3(d).
F8: The stock options become exercisable in three (3) equal annual installments, commencing one year after the grant date of 06/19/2008.